4 years of revenue, earnings, cash-flow and balance-sheet history from public filings.
Processa Pharmaceuticals, Inc. (PCSA) operates in the Biotechnology industry and is headquartered in Vero Beach, United States with about 12 employees. Its market capitalization is roughly $5 million. In the fiscal year ended 2025-12-31, PCSA reported $0M in revenue and ($14M) in net income.
Processa Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops cancer therapy drugs to improve the safety and efficacy of cancer treatment in the United States.
Interactive charts & full statements →
| Income statement | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Total Revenue | $0M | $0M | $0M | $0M | — |
| Operating Income (EBIT) | ($14M) | ($12M) | ($12M) | ($20M) | — |
| Net Income | ($14M) | ($12M) | ($11M) | ($27M) | — |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Quarterly income statement | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
|---|---|---|---|---|---|---|
| Total Revenue | $0M | $0M | $0M | $0M | $0M | — |
| Operating Income (EBIT) | ($3M) | ($4M) | ($4M) | ($4M) | ($3M) | — |
| Net Income | ($3M) | ($3M) | ($3M) | ($4M) | ($3M) | — |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Balance sheet | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Total Assets | $8M | $3M | $6M | $9M | — |
| Total Liabilities | $2M | $2M | $1M | $1M | — |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
Quarterly statements, profitability ratios, price history, insider activity and institutional holders are in the interactive PCSA viewer.
About TickerBase · Data methodology & sources